SSRM Earnings

SSRM reported its FY2025Q4 earnings on 2026-02-17, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.66 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following SSRM's FY2025Q4 earnings announcement on 2026-02-17, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, SSRM's stock price tends to shift by an average of +12.77% in the 10 days leading up to earnings and +1.02% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate SSRM’s annual revenue to reach 482.63M, while the EPS is projected at 0.65. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 4.2% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between SSRM's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 4.2%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SSRM's stock price typically moves by +12.77% in the 10 days before its earnings and +1.02% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.65 and revenue of 482.63M.

The earnings call presents a mixed picture. Positive elements include strong free cash flow, substantial liquidity, and optimistic Q4 expectations from Marigold. However, challenges such as Çöpler's restart delays, operational issues at Seabee, and permitting at CC&V present risks. The Q&A reveals management's focus on addressing these issues but lacks definitive timelines, particularly for Çöpler. The company's strategic focus on organic growth and disciplined M&A is promising but lacks immediate catalysts. Overall, the sentiment is neutral, with potential for slight positive movement if operational issues are resolved efficiently.